Time Magazine released its 50 most influential in healthcare for 2018 list, recognizing those in the sector that are leaders in public health, treatment, cost and technology initiatives.

Black men with prostate cancer may have “comparatively higher” cure rates than white men when treated with radiation therapy, according to study results presented Oct. 22 at the American Society for Radiation Oncology (ASTRO) Annual Meeting in San Antonio, Texas.

Molecular imaging societies have numerous recommendations for patients with diabetes who undergo fluoride-18 fluorodeoxyglucose (FDG) PET/CT tumor imaging. According to new research published in the Journal of the American College of Radiology, however, many providers are not explaining these things to patients when appointments are scheduled.

CMS and the Treasury Department have introduced new guidance on health insurance markets that will allow states to sell plans with looser restrictions.

SHINE Medical Technologies, a Monona, Wisconsin-based medical isotope manufacturer, is now closer to producing molybdenum-99 (Mo-99) after receiving a new custom-designed production accelerator.

President Trump tweeted Oct. 18 that all Republicans support patients with pre-existing conditions, “and if they don’t, they will after I speak to them”—a sentiment that directly contradicts the Trump administration’s efforts to strip the Affordable Care Act of its protections for such patients.

The “flipped classroom” learning methodology proved to be a positive experience for fourth-year medical students at the University of California Riverside School of Medicine, according to new research published in the Journal of the American College of Radiology.

Today, Medical Group Management Association (MGMA) proudly announces its 2018-2019 Board of Directors.